Pfizer Inc. Recall: Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use
Pfizer Inc. Recall: Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Pfizer Inc.; Product: Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx only, Distributed by Pfizer Labs, Division of
| Recalling firm | Pfizer Inc. |
|---|---|
| Product | Elelyso (taliglucerase alfa) for injection, 200 units/vial, single-use vial, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017, NDC 0069-0106-01 |
| Reason for recall | Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | U.S.A. nationwide. The following countries received product from Lot S91616: Albania, South Africa, Israel, Afghanistan, Rwanda, Botswana, Zimbabwe and Iraq as part of the Compassionate Use Program. |
| Recall initiated | 20180919 |
| Recall number | D-0005-2019 |
| Category | drug |
| State | NY |
| Country | United States |
$29/mo
Try RecallGuard →